Merge Healthcare Signs Agreement with Radiology Detector Distributor in China
|
By MedImaging International staff writers Posted on 01 Dec 2009 |
Merge Healthcare (Milwaukee, WI, USA), a medical imaging solutions provider, reported that its Merge China business unit has signed a distribution agreement with Pangaea Technology, Ltd. (Hong Kong SAR, China), a distributor of charged couple device (CCD) detectors, which are an economic alternative to digital detectors, for digital radiography (DR) systems in the Greater China area. Pangaea will provide the Chinese DR market with a bundled system consisting of Merge CIE (Cedara Image Enhancement) and CCD through their eight offices and wide distribution channels in China.
"After the healthcare reform plan was announced in China early this year, we recognized that there would be large demand for economical DR solutions in the rural healthcare market. Many local modality manufacturers have since switched their product lines to address a cost conscious, big volume market. We believe the CCD sensor and Merge CIE is a solution that will fit into this market perfectly,” explained Richard Fung, CEO and president of Pangaea (HK) Limited, which is the parent company of Pangaea China. "During this preliminary stage of work with Merge China, our customers are quite happy and satisfied with the enhanced images filtered by CIE, the flexibility of the tuning tools, and the timely response through Merge's local technical team. With Merge's extensive knowledge and advanced technologies in the medical imaging domain, we expect to dramatically grow our CCD shipment during 2010, and we are looking at the healthcare industry as our key growth market in the future.”
"Pangaea is a very important distributor in China for our CIE solution,” said Justin Dearborn, Merge CEO. "The quality and cost of the CCD has been well recognized by the market, and Pangaea's wide distribution channel and existing customer base has already shown significant interest in the bundled solution. This is a perfect combination of technologies and marketing channels, and we look forward to bringing more of our technologies to their solution in the future.”
Pangaea, headquartered in Hong Kong, was founded in 1990 as a distribution company offering advanced solutions for telecommunication, healthcare, industrial, and consumer electronics. Pangaea has a broad customer base in China and is currently having eight offices in China offering sales and technical support to customers.
Merge Healthcare develops software solutions that automate healthcare data and diagnostic workflow to create a more comprehensive electronic record of the patient experience.
Related Links:
Merge Healthcare
Pangaea
"After the healthcare reform plan was announced in China early this year, we recognized that there would be large demand for economical DR solutions in the rural healthcare market. Many local modality manufacturers have since switched their product lines to address a cost conscious, big volume market. We believe the CCD sensor and Merge CIE is a solution that will fit into this market perfectly,” explained Richard Fung, CEO and president of Pangaea (HK) Limited, which is the parent company of Pangaea China. "During this preliminary stage of work with Merge China, our customers are quite happy and satisfied with the enhanced images filtered by CIE, the flexibility of the tuning tools, and the timely response through Merge's local technical team. With Merge's extensive knowledge and advanced technologies in the medical imaging domain, we expect to dramatically grow our CCD shipment during 2010, and we are looking at the healthcare industry as our key growth market in the future.”
"Pangaea is a very important distributor in China for our CIE solution,” said Justin Dearborn, Merge CEO. "The quality and cost of the CCD has been well recognized by the market, and Pangaea's wide distribution channel and existing customer base has already shown significant interest in the bundled solution. This is a perfect combination of technologies and marketing channels, and we look forward to bringing more of our technologies to their solution in the future.”
Pangaea, headquartered in Hong Kong, was founded in 1990 as a distribution company offering advanced solutions for telecommunication, healthcare, industrial, and consumer electronics. Pangaea has a broad customer base in China and is currently having eight offices in China offering sales and technical support to customers.
Merge Healthcare develops software solutions that automate healthcare data and diagnostic workflow to create a more comprehensive electronic record of the patient experience.
Related Links:
Merge Healthcare
Pangaea
Latest Industry News News
- GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
- GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channelNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







